Managing risks of TNF inhibitors: An update for the internist

Jennifer Hadam, Elie Aoun, Kofi Clarke, Mary Chester Wasko

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

Tumor necrosis factor (TNF) inhibitors have many beneficial effects, but they also pose infrequent but significant risks, including serious infection and malignancy. These risks can be minimized by judicious patient selection, appropriate screening, careful monitoring during treatment, and close communication between primary care physicians and subspecialists.

Original languageEnglish (US)
Pages (from-to)115-127
Number of pages13
JournalCleveland Clinic journal of medicine
Volume81
Issue number2
DOIs
StatePublished - Feb 1 2014

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Managing risks of TNF inhibitors: An update for the internist'. Together they form a unique fingerprint.

  • Cite this